Literature DB >> 21672998

Safety of tiotropium.

Christopher J Cates.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21672998     DOI： 10.1136/bmj.d2970

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Tiotropium formulations and safety: a network meta-analysis.

Authors:  Mario Cazzola; Luigino Calzetta; Paola Rogliani; Maria Gabriella Matera
Journal:  Ther Adv Drug Saf       Date:  2016-09-16

Review 2.  Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews.

Authors:  Christopher J Cates; Marta Oleszczuk; Elizabeth Stovold; L Susan Wieland
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

Review 3.  Risks associated with tiotropium in chronic obstructive pulmonary disease: overview of the evidence to date.

Authors:  Yoon K Loke; Sonal Singh
Journal:  Ther Adv Drug Saf       Date:  2012-06

Review 4.  Tiotropium versus placebo for chronic obstructive pulmonary disease.

Authors:  Charlotta Karner; Jimmy Chong; Phillippa Poole
Journal:  Cochrane Database Syst Rev       Date:  2014-07-21

5.  A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD.

Authors:  Michele Jara; Charles Wentworth; Stephan Lanes
Journal:  BMJ Open       Date:  2012-05-22       Impact factor: 2.692
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.